About Fynexo BT Tablet
Experience opulent relief from allergic symptoms and respiratory allergies with the new Fynexo-BT Tablet. Marketed by Define Pharmaceuticals Pvt. Ltd. and renowned for its towering efficacy, this prescription medication fuses Fexofenadine Hydrochloride and Montelukast Sodium in a finished formulation. Redeem robust results in treating allergic rhinitis, asthma, and urticaria. Each oval, light brown tablet ensures effective anti-allergic action, with WHO-GMP certification affirming its safety. Purchase Fynexo-BT in convenient strips and enjoy a remarked advancement in allergy management, exclusively for adult use.
Application Method and Areas for Fynexo BT Tablet
Fynexo BT Tablet is administered once daily or as prescribed by a physician. Specifically recommended for adults, it targets respiratory allergies and allergic symptoms including rhinitis, asthma, and urticaria. The application area encompasses respiratory tracts and immune response modulation. Used predominantly by individuals seeking relief from allergic disturbances, it is strictly for prescription use and should not be administered to children under 12 unless directed by a healthcare professional.
Supply Ability, Packaging, and Certifications for Fynexo BT Tablets
With efficient order processing and reliable freight services, Fynexo BT Tablet is available for bulk purchase from trusted suppliers in India. Each sale is fulfilled with secure packaging: 10 tablets per strip and 10 strips per box. The product's regulatory excellence is remarked by its WHO-GMP certification, assuring opulent quality standards. Competitive sale prices are offered for distributors, exporters, and manufacturers ensuring dependable delivery throughout the product lifespan.
FAQ's of Fynexo BT Tablet:
Q: How should Fynexo BT Tablet be used for optimal results?
A: Fynexo BT Tablet should be taken once daily or exactly as prescribed by your healthcare provider. It is best suited for adult patients experiencing allergic symptoms or respiratory allergies.
Q: What health conditions does Fynexo BT Tablet address?
A: This tablet is indicated for the treatment of allergic rhinitis, asthma, and urticaria, helping to relieve symptoms like sneezing, congestion, and respiratory discomfort.
Q: When is Fynexo BT Tablet not recommended for use?
A: Fynexo BT Tablet is not recommended for children under 12 years old except under strict medical supervision, as its safety in this age group is not established without a physician's guidance.
Q: Where should Fynexo BT Tablets be stored?
A: Store Fynexo BT Tablets in a cool, dry place, away from direct sunlight and moisture, to preserve their efficacy for up to 24 months from the manufacturing date.
Q: What are the side effects of Fynexo BT Tablet and how should they be managed?
A: Mild side effects could include drowsiness, headache, or dry mouth. If these symptoms become severe or persistent, consult your doctor for advice or alternative treatment options.
Q: What certifications does Fynexo BT Tablet have to guarantee its quality?
A: Fynexo BT Tablet is certified by WHO-GMP, reflecting its adherence to global manufacturing standards and remarked safety in pharmaceutical production processes.